Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Bioenergy Life Science, Inc. |
---|---|
Information provided by: | Bioenergy Life Science, Inc. |
ClinicalTrials.gov Identifier: | NCT00821067 |
D-ribose, a natural occurring pentose carbohydrate, has repeatedly shown to enhance high-energy phosphates and improve function following ischemia, states of congestive heart failure, and recently in subjects with lung disease. An initial preliminary, open label pilot study demonstrated a positive benefit of D-ribose in "Baby-Boomer" subjects aged 50 to 65 years old complaining of persistent fatigue. The objective of this study will build on the previously collected data to evaluate oral D-ribose vs. dextrose (administered as a supplement) in relatively healthy, yet fatigued subjects with a goal of improving their state of fatigue.
Condition | Intervention |
---|---|
Fatigue |
Dietary Supplement: D-ribose Dietary Supplement: Dextrose |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Parallel Assignment, Efficacy Study |
Official Title: | The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind, Multi-Center Study |
Estimated Enrollment: | 40 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | May 2009 |
Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
A 6 gm/day (3 gm/bid) dose of D-ribose
|
Dietary Supplement: D-ribose
A 6 gm/day (3 gm/bid) dose of D-ribose in water. Each subject will consume oral D-ribose, dissolved in 8 fl. oz of water (1 serving) twice daily, for 2 weeks.
|
2: Placebo Comparator
A 6 gm/day (3 gm/bid) dose of dextrose.
|
Dietary Supplement: Dextrose
A 6 gm/day (3 gm/bid) dose of dextrose in water. Each subject will consume oral dextrose, dissolved in 8 fl. oz of water (1 serving) twice daily, for 2 weeks.
|
Ages Eligible for Study: | 50 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Additional Exclusions observed and sequelae during initial baseline evaluation:
United States, Colorado | |
Aurora Denver Cardiology Association | |
Denver, Colorado, United States, 80218 | |
United States, Pennsylvania | |
Abington Memorial Hospital | |
Abington, Pennsylvania, United States, 19001 |
Study Director: | Dean MacCarter, PhD | Aurora Denver Cardiology Association |
Responsible Party: | Bioenergy Life Science, Inc. ( Jeff Thompson ) |
Study ID Numbers: | FS20081121 |
Study First Received: | January 9, 2009 |
Last Updated: | January 12, 2009 |
ClinicalTrials.gov Identifier: | NCT00821067 |
Health Authority: | United States: Institutional Review Board |
Signs and Symptoms Fatigue |